IL6 and Lyme disease: IL‐6 was the predominant cytokine in skin lesions (“erythema migrans”) of Lyme borreliosis patients and is strongly induced in Borrelia‐stimulated human monocytes in vitro (Cervantes et al., 2011; Salazar et al., 2003).